戻る Agenda
New Developments in CDER/CDRH Working Framework
Session Chair(s)
Azin Shahzamani
Senior Director, Regulatory Affairs
Genentech, A Member of the Roche Group, United States
Speaker(s)
Speakers
Jeff Allen, PHD
Friends of Cancer Research, United States
President and Chief Executive Officer
Speakers
Pamela Bradley
FDA, United States
Staff Fellow, Office of In Vitro Diagnostics & Radiological Health, CDRH
Speakers
Christopher Leptak, MD, PHD
Greenleaf Health, Inc., United States
Executive Vice President, Drug and Biological Products
Speakers
Mya Thomae, RAC
Myraqa, United States
Founder and Chief Executive Officer